SGLT as a therapeutic target

Drugs of the Future

Volumn 29, Issue 5, 2004, Pages 461-466

  Asano, Tomoichiro ^a   Anai, Motonobu ^b   Sakoda, Hideyuki ^c   Fujishiro, Midori ^c   Ono, Hiraku ^b   Kurihara, Hiroki ^a   Uchijima, Yasunobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (5 BENZOFURANYL) 1 [2 HYDROXY 6 [6 O (METHOXYCARBONYL) BETA DEXTRO GLUCOPYRANOSYL] 4 METHYLPHENYL] 1 PROPANONE; COTRANSPORTER; FATTY ACID; HEMOGLOBIN A1C; INSULIN RECEPTOR SUBSTRATE 1; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASOLATERAL MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG STRUCTURE; DRUG TARGETING; GLUCOSURIA; HYPERGLYCEMIA; HYPOGLYCEMIA; INJECTION; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY TUBULE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVIEW; STREPTOZOCIN DIABETES;

EID: 3242890250     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2004.029.05.850959     Document Type: Review

References (19)

1. Leahy, J., Bonner-Weir, S., Weir, G. β-Cell dysfunction induced by chronic hyperglycemia: Current ideas on mechanism of impaired glucose induced insulin secretion. Diabetes Care 1992, 15: 442-5.
2. Rossetti, L., Giaccari, A., DeFronzo, R. Glucose toxicity. Diabetes Care 1990, 13: 610-30.
3. Rossetti, L., Cusin, I., Tiengo, A. et al. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987, 79: 1510-5.
4. Blondel, O., Bailbe, D., Portha, B. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: Evidence for reversal following phlorizin treatment. Metabolism 1990, 39: 787-97.
5. +-glucose cotransporters, may provide a novel approach to treating diabetes. Diabetes 1999, 48: 1794-800.
6. Turk, E., Wright, E.M. Membrane topology motifs in the SGLT cotransporter family. J Membr Biol 1997, 159: 1-20.
7. +/proline cotransporters. Proc Natl Acad Sci USA 1989, 86: 5748-52.
8. +/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 1994, 93: 397-404.
9. +-glucose cotransporters in streptozotocin-induced diabetic rats. Biol Pharm Bull 2000, 23: 1434-7.
10. +-glucose cotransporter inhibitor T-1095. Brit J Pharmacol 2001, 132: 578-86.
11. +-glucose cotransporter, in neonatally streptozotocin-treated rats. Eur J Pharmacol 2000, 391: 183-92.
12. Nawano, M., Oku, A., Ueta, K. et al. Hyperglycemia contributes to insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol Endcrinol Metab 2000, 278: E535-43.
13. Stern, D., Yan, S.D., Yan, S.F. et al. Receptor for advanced glycation endproducts: A multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002, 54: 1615-25.
14. Pennathur, S., Heinecke, J.W. Mechanisms of oxidative stress in diabetes: Implications for the pathogenesis of vascular disease and antioxidant therapy. Front Biosci 2004, 9: 565-74.
15. Evans, J.L., Goldfine, I.D., Maddux, B.A. et al. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocrin Rev 2002, 23: 599-622.
16. +-glucose cotransporters, on metabolic index and insulin secretion in spontaneously diabetic GK rats. Clin Exp Pharmacol Physiol 2002, 29: 386-90.
17. +-glucose co-transporters. Horm Metab Res 2002, 34: 217-21.
18. Oku, A., Nawano, M., Ueta, K. et al. Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle. Am J Physiol Endocrinol Metab 2001, 280: E816-24.
19. Nawano, M., Ueta, K., Oku, A. et al. Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver. Biochem Biophys Res Comm 1999, 266: 252-6.